J. Payne

发表

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling

C. Hassig, J. Hager, M. Mapara, 2008, Molecular Cancer Therapeutics.

Pharmacological Characterization of KLYP961, a Dual Inhibitor of Inducible and Neuronal Nitric-Oxide Synthases

Nahid M. Yazdani, T. Rao, A. Shiau, 2011, Journal of Pharmacology and Experimental Therapeutics.

Property-Driven Design and Development of Lipids for Efficient Delivery of siRNA.

R. Mukthavaram, P. Karmali, P. Limphong, 2020, Journal of medicinal chemistry.

Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS

Nahid M. Yazdani, T. Rao, A. Shiau, 2010, Journal of medicinal chemistry.

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo

A. Saven, T. Rao, J. Malecha, 2008, Molecular Cancer Therapeutics.

Identification of KD5170: a novel mercaptoketone-based histone deacetylase inhibitor.

T. Rao, J. Malecha, T. Z. Hoffman, 2008, Bioorganic & medicinal chemistry letters.

Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.

Nahid M. Yazdani, J. Walsh, T. Rao, 2009, Journal of medicinal chemistry.

Synthesis of (+/-)-bakkenolide-A and its C-7, C-10, and C-7,10 epimers by means of an intramolecular Diels-Alder reaction.

T. G. Back, J. Payne, V. Nava-Salgado, 2001, The Journal of organic chemistry.

Primate Spinothalamic Tract Neurons Nitric Oxide Mediates the Central Sensitization of

Nahid M. Yazdani, W. Willis, T. Symons, 2015 .

Novel approach to pro-drugs of lactones: water soluble imidate and ortho-ester derivatives of a furanone-based COX-2 selective inhibitor.

B. Muñoz, N. Smith, Steve F. Poon, 2005, Bioorganic & medicinal chemistry letters.

Immune modulatory nanoparticle therapeutics for intracerebral glioma

Shouhao Zhou, A. Heimberger, K. Gabrusiewicz, 2016, Neuro-oncology.

KD 5170 , a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo

A. Saven, T. Rao, J. Malecha, 2008 .

Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function

M. Roden, S. Herzig, M. Blüher, 2021, bioRxiv.

Abstract 4291: An optimized therapeutic nanoparticle delivery platform of miRNA in preclinical murine models of malignancy

Shouhao Zhou, A. Heimberger, Xiaoyang Ling, 2015 .

Water soluble prodrug of a COX-2 selective inhibitor suitable for intravenous administration in models of cerebral ischemia.

D. Lorrain, P. Prasit, B. Muñoz, 2005, Bioorganic & medicinal chemistry letters.

Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists.

Joseph Payne, Vijay T. Ahuja, Yue-Zhong Shu, 2009, Journal of medicinal chemistry.

Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS

Nahid M. Yazdani, T. Rao, A. Shiau, 2010, Journal of medicinal chemistry.

KLYP956 Is a Non-Imidazole-Based Orally Active Inhibitor of Nitric-Oxide Synthase Dimerization

T. Rao, A. Shiau, C. Hassig, 2009, Molecular Pharmacology.